Purpose of the study:
The objective of this study is to compare the effectiveness of the test medication under study to that of a
medication that is already on the market for the treatment of moderate to severe acne.
Study Information:
- The study will last approximately eleven (11) weeks.
- Participation in the study is free of charge. All assessments, visits, and study medication is at no-cost.
- There will be a total of four (4) patient visits during the course of the study.
- The principal investigator is David Kerr, M.D.
- The principal coordinator of the study is Isabel Arnold BSN, RN, CCRC
To qualify for the study you must:
- Be male or non-pregnant, non-lactating female, 12 years of age or older.
- If female and of child-bearing potential, prepare to abstain from sexual intercourse or use a reliable method of
contraception during the study (e.g., condom, IUD, injected or implanted hormonal contraceptives). Patients on
hormonal contraceptives must have been on the same hormonal contraceptive for three (3) months prior to the first
visit and continue throughout the duration of the study.
- Have moderate to severe facial acne.
To qualify for the study you must NOT:
- Have significant facial hair such as beards, or tattoos, or excessive facial scarring.
- Have an active facial sunburn, or peeling due to sunburn.
- Be female who is pregnant, lactating or likely to become pregnant during the study.
- Use any topical antibiotics, topical steroids or topical anti-inflammatory products used on the face or any oral
antibiotics known to treat acne.
- Have used oral Accutane® within six (6) months, or have used topical Retin-A®, Differin®, Taxorac®,or Azelex®
within twenty eight (28) days of starting the study.
- Have received any drug as part of a research study within thirty (30) days prior to starting the study.
- Have used any antibacterial or medicated products on the face (soap, lotions, moisturizers, etc.) or other facial
cleansing agents for fourteen (14) days prior to study enrollment.
To participate in the study or for more information:
If you would like to participate in this study please click here and complete the questionnaire.
If you would like additional information about participating in this study you can also call 303-
399-4067.
Actinic Keratosis (AK) is a fairly common skin problem, especially here in Colorado where we are known to have an
active outdoor lifestyle and where the sun can be quite intense. This skin affliction is nearly always caused by long-
term and frequent exposure to the sun. If you have been diagnosed with AK, you might be eligible to participate in a
clinical research study investigating the comparative effectiveness of two FDA approved medications.
Study Information:
- The study will last twenty four (24) weeks.
- Participation in the study is free of charge. All assessments, visits, and study medication is at no-cost.
- Study participants will receive compensation for their time and travel.
- There will be a total of four (4) patient visits during the course of the study.
- The principal investigator is David Kerr, M.D.
- The principal coordinator of the study is Isabel Arnold RN, BSN, CCRC
To qualify for the study you must:
- Be male or non-pregnant, non-lactating female, 18 years of age or older.
- Have been diagnosed with 4-8 AK lesions on your face or balding scalp.
- If female either be one year menopausal, surgically sterile, agree to use a medically accepted form of birth control,
or attest to abstinence.
- Be free of any systemic or dermatological disorder.
To qualify for the study you must NOT:
- Have a history of facial irritation to topical products.
- Engage in activities involving excessive or prolonged exposure to sunlight.
- Be currently using or have used systemic steroids two months prior to the study.
To participate in the study or for more information:
If you would like to participate in this study please click here and complete the questionnaire.
If you would like additional information about participating in this study you can also call 303-399-4067.
We will very shortly begin enrolling volunteer participants for a new clinical research study in the treatment of
eczema. Please check this page again soon for more information.
|
